Leef Brands Inc. (CSE: LEEF)
LEEF trades on the Canadian Securities Exchange in Life Sciences. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 16, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for LEEF.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 10-K text ("our website").
Profile
| Field | Value |
|---|---|
| Ticker | LEEF on the Canadian Securities Exchange |
| Yahoo symbol | LEEF.CN |
| Sector | Life Sciences, Drug Manufacturers—Specialty & Generic |
| Headquarters | The TMX list gives no head office |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 305,556,473 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001711141 |
| Website | www.leefbrands.com |
Returns
| Window | Return |
|---|---|
| 1 day | +4.8% |
| 1 week | -10.2% |
| 1 month | -2.2% |
| 3 months | -20.0% |
| 6 months | +2.3% |
| Year to date | +4.8% |
| 1 year | -12.0% |
| From 52-week high | -29.0% |
| 52-week range | C$0.1450 to C$0.3100 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
77 documents in 8 types. Each title links to the document at its source.
News release (4)
| Document | Type | Filed |
|---|---|---|
| LEEF Brands Inc. | News release (8-K) | 2026-10-02 |
| Press release dated July 27, 2026 | News release (8-K) | 2026-08-03 |
| Press release dated April 28, 2026 | News release (8-K) | 2026-05-05 |
| Press release dated April 16, 2026 | News release (8-K) | 2026-04-20 |
Prospectus (4)
| Document | Type | Filed |
|---|---|---|
| S-1 | Prospectus (long form) (S-1) | 2026-07-09 |
| S-1/A | Prospectus (long form) (S-1/A) | 2025-12-23 |
| S-1/A | Prospectus (long form) (S-1/A) | 2025-11-07 |
| S-1 | Prospectus (long form) (S-1) | 2025-08-26 |
Annual report (1)
| Document | Type | Filed |
|---|---|---|
| 10-K Period 2025-12-31 | Annual report (10-K) (10-K) | 2026-03-26 |
Quarterly report (2)
| Document | Type | Filed |
|---|---|---|
| 10-Q Period 2026-06-30 | Quarterly report (10-Q) (10-Q) | 2026-08-06 |
| 10-Q Period 2026-03-31 | Quarterly report (10-Q) (10-Q) | 2026-05-06 |
Early warning / ownership (2)
| Document | Type | Filed |
|---|---|---|
| Schedule 13D | Schedule 13D (SCHEDULE 13D) | 2026-04-01 |
| Schedule 13G | Schedule 13G (SCHEDULE 13G) | 2026-05-22 |
Insider report (18)
| Document | Type | Filed |
|---|---|---|
| Form 3 | Form 3 (3) | 2026-10-02 |
| Form 3 | Form 3 (3) | 2026-10-02 |
| Form 3 | Form 3 (3) | 2026-04-24 |
| Form 3 | Form 3 (3) | 2026-04-08 |
Certification (12)
| Document | Type | Filed |
|---|---|---|
| EX-31.1 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-08-06 |
| EX-31.2 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-08-06 |
| EX-32.1 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-08-06 |
| EX-32.2 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-08-06 |
Other (34)
| Document | Type | Filed |
|---|---|---|
| 8-K | Current report (8-K) (8-K) | 2026-10-02 |
| 8-K | Current report (8-K) (8-K) | 2026-08-03 |
| 8-K | Current report (8-K) (8-K) | 2026-06-02 |
| 8-K | Current report (8-K) (8-K) | 2026-05-05 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2021-05-11 | Equity | US$110K | US$110K | SEC EDGAR |
| 2019-09-17 | Equity | US$405K | US$405K | SEC EDGAR |
| 2019-09-10 | Equity | US$8.6M | US$8.6M | SEC EDGAR |
| 2017-07-21 | Equity, Option To Acquire, Security To Be Acquired | US$68K | US$135K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| EK | Everkind Wellness Inc. | TSXV | C$65.0M | -27.8% | Under a year of closes |
| TELY | TelyRx Holdings Inc. | TSX | C$64.3M | -25.7% | Under a year of closes |
| AAWH.U | Ascend Wellness Holdings, Inc. | CSE | C$73.2M | -16.3% | -41.9% |
| HBP | Helix BioPharma Corp. | TSX | C$75.6M | -11.5% | -61.9% |
| PCRX | PharmaCorp Rx Inc. | TSXV | C$78.8M | +2.5% | -4.7% |
The app has the price chart, every filing, private raises and the full peer set for LEEF.
Open in the app